AstraZeneca 拟以约 $10B 收购 Rhythm Pharmaceuticals
AstraZeneca recently made a roughly $10 billion offer to buy Rhythm Pharmaceuticals, a deal that would expand its portfolio of rare disease treatments...
AI 导读
WSJ Markets 援引报道，AstraZeneca 近期向 Rhythm Pharmaceuticals 发出约 $10B 的收购要约。该交易若达成，将扩充其在罕见病治疗领域的组合。